Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Latexin Antibody-FITC (6A829) (Synonyms: latexin)

Catalog No. TMAY-00471F Copy Product Info
🥰Excellent
Anti-Latexin Antibody-FITC (6A829) is a FITC-conjugated Mouse antibody targeting Latexin. Anti-Latexin Antibody-FITC (6A829) can be used in FCM.

Anti-Latexin Antibody-FITC (6A829)

Copy Product Info
🥰Excellent
Catalog No. TMAY-00471F
Synonyms latexin

Anti-Latexin Antibody-FITC (6A829) is a FITC-conjugated Mouse antibody targeting Latexin. Anti-Latexin Antibody-FITC (6A829) can be used in FCM.

Anti-Latexin Antibody-FITC
(6A829)
Pack SizePriceUSA StockGlobal StockQuantity
25 T$1057-10 days7-10 days
100 T$2117-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-Latexin Antibody-FITC (6A829) is a FITC-conjugated Mouse antibody targeting Latexin. Anti-Latexin Antibody-FITC (6A829) can be used in FCM.
Synonymslatexin
Ig Type
Mouse IgG1
Clone
6A829
Reactivity
Human
Specificity
Human Latexin
Verified Activity
Human LXN expression in MCF-7 cells. The cells were treated according to manufacturer’s manual (BD Pharmingen™ Cat. No. 554714), and stained with FITC Mouse anti-LXN. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.
Application
Recommended Dose
10 μl/Test, 0.1 mg/ml
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Latexin / Lxn (rh Latexin / Lxn; TMPY-00870; NP_064554.3; Glu 2-Glu 222) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
PurificationProtein A
AppearanceLiquid
FormulationPBS solution containing 0.5% BSA and 0.1% sodium azide
Research BackgroundLatexin, also known as endogenous carboxypeptidase inhibitor, tissue carboxypeptidase inhibitor, TCI, ECI, and LXN, is a cytoplasm protein that belongs to the protease inhibitor I47 (latexin) family. It is highly expressed in the heart, prostate, ovary, kidney, pancreas, and colon. Latexin / LXN is the only known endogenous specific inhibitor of zinc-dependent metallocarboxypeptidases (MCPs) present in mammalians so far. Latexin is originally identified as a molecular marker for the regional specification of the neocortex in development in rats. The 222 amino acid latexin in the human shows different expression distribution with high levels in heart, prostate, ovary, kidney, pancreas, and colon, but only moderate or low levels in other tissues including the brain. Latexin is also expressed at high levels and is inducible in macrophages in concert with other protease inhibitors and potential protease targets, and thus is suggested to play a role in inflammation and innate immunity pathways. Despite the non-detectable sequence similarity with plant and parasite inhibitors, Latexin is related to a human putative tumor suppressor protein, TIG1. Also, Latexin is implicated in Alzheimer's disease.
Related Conjugates and Formulations
Conjucates
FITC
Others Formats
Unconjugated/PE
Antibody Types Available
3
Antigen Details
Immunogen
Recombinant Protein: Human Latexin / Lxn protein (TMPY-00870)
Antigen Species
Human
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-Latexin Antibody-FITC (6A829) | purchase Anti-Latexin Antibody-FITC (6A829) | Anti-Latexin Antibody-FITC (6A829) cost | order Anti-Latexin Antibody-FITC (6A829)